Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Healthcare Biotechnology
Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune... see more

Bullboard (TSX:ONC)

View:
Prev ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... Next
Comment by Noteableon Apr 25, 2024 12:09pm

RE:RE:RE:RE:CD8+ TiLs and T-cell exhaustion

ONCY's drug platform pelareorep is part of that promising future referenced in the previous post. In particular,  ONCY's AWARE-1 study showed that pelareorep treatment upregulated ...more  
59
Discussion
Comment by Noteableon Apr 25, 2024 12:05pm

RE:RE:RE:CD8+ TiLs and T-cell exhaustion

https://stockhouse.com/companies/bullboard/t.onc/oncolytics-biotech-inc?postid=36006537
45
Discussion
Comment by Noteableon Apr 25, 2024 12:04pm

RE:RE:New Press Release - Oncolytics Biotech® Announces Upcoming Presentations at the American Society of Clinical Oncology Annual Meeting

CD8+ TiL cells are critical mediators of cytotoxic effector function in cancer, however, in cancer, CD8+ TiL cells undergo a progressive loss of cytokine production and cytotoxicity, a state ...more  
64
Discussion
Comment by Lesalpes29on Apr 25, 2024 8:20am

RE:New Press Release - Oncolytics Biotech® Announces Upcoming Presentations at the American Society of Clinical Oncology Annual Meeting

Positive NR. We are still in the game! Will add a few more today. This year as to be the YEAR where we all long shareholders are going to be rewarded. Roche is watching us closely! GL 
190
Discussion
Comment by Azzak34on Apr 25, 2024 8:02am

RE:New Press Release - Oncolytics Biotech® Announces Upcoming Presentations at the American Society of Clinical Oncology Annual Meeting

https://www.cancer.gov/news-events/cancer-currents-blog/2023/oncolytic-virus-blocking-tgf-beta A major rate-limiting factor with oncolytic virus continues to be the need to inject them directly ...more  
113
Discussion
Post by canadafanon Apr 25, 2024 8:01am

Todays announcement

Onc announced today upcoming presentation at an annual oncology conference. they have two posters. One regarding details of anal cancer trail the other? Seems very vague.  my best guess ...more  
189
Comment by spesestsemperon Apr 24, 2024 8:21pm

RE:RE:fda tracking number

the last post was under the Show Definitional References link  
71
Discussion
Comment by spesestsemperon Apr 24, 2024 8:18pm

RE:fda tracking number

this was the update near the end of last year Reovirus type 3 (strain Dearing) (T3D) | Taxonomy | UniProt
70
Discussion
Post by spesestsemperon Apr 24, 2024 8:15pm

fda tracking number

UNII - S9J80L3D1U (fda.gov) PELAREOREP (nih.gov) couple of links to look over
132
Discussion
Comment by Jf4270393on Apr 24, 2024 7:23pm

RE:RE:The Calm Before the Storm.

Why are you here? Do you attend funerals of random people?
54
Discussion
Post by CMHarring218431on Apr 24, 2024 6:22pm

Strength

With all the possible multiple applications Pela could be involved in, that is, different cancers.... I hope management has the staying power/stamina and resources to withstand big pharma delay in ...more  
143
Comment by Azzak34on Apr 24, 2024 4:00pm

RE:RE:The Calm Before the Storm.

Sure is Buckster. Selling pressure gone, for now, and everyone is waiting to jump on. You should buy a few shares before they get too expensive. 
73
Discussion
Comment by Buckhenryon Apr 24, 2024 3:49pm

RE:The Calm Before the Storm.

Low volume is more likely do to folks waiting to see if this dead horse gets revived by some miracle. 
56
Discussion
Prev ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities